Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

A schematic diagram of the development of next-generation RNA gene editing technology using induction evolution The Catholic ...

Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

The Swiss drugmaker said it was “encouraged” by the signs of effectiveness of the drug, developed by biotech Prothena, showed ...

Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson’s disease with over ...

Morten Harket, frontman of the Norwegian ’80s new wave band A-ha, has Parkinson’s disease. Harket opens up about his ...

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in ...